Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors. Bioorganic & Medicinal Chemistry Letters, 2017
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors. Nature Communications, 2017
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017
